These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8466089)

  • 1. Evaluation of responses to pneumococcal vaccine.
    Kline MW; Shearer WT
    Ann Allergy; 1993 Apr; 70(4):261. PubMed ID: 8466089
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of bacterial vaccines in prevention of respiratory infections with special reference to pneumococcal vaccines.
    Huchon G
    Postgrad Med J; 1983; 59 Suppl 3():185-7. PubMed ID: 6647205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease.
    Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC
    J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children.
    Barnett ED; Pelton SI; Cabral HJ; Eavey RD; Allen C; Cunningham MJ; McNamara ER; Klein JO
    Clin Infect Dis; 1999 Jul; 29(1):191-2. PubMed ID: 10433584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of new pneumococcal vaccines: the Finnish approach.
    Eskola J; Takala AK; Kilpi TM; Lankinen KS; Käyhty H
    Dev Biol Stand; 1998; 95():85-92. PubMed ID: 9855418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of postimmunization pneumococcal titers in children with recurrent infections and normal levels of immunoglobulin.
    Zora JA; Silk HJ; Tinkelman DG
    Ann Allergy; 1993 Apr; 70(4):283-8. PubMed ID: 8466092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB; Carter AT; Hitchin E; Wells JM
    J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal vaccine: overcoming barriers to use.
    Tamblyn SE
    CMAJ; 1998 Jan; 158(1):87-8. PubMed ID: 9475917
    [No Abstract]   [Full Text] [Related]  

  • 9. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?
    Dagan R
    Vaccine; 2008 Jun; 26 Suppl 2():B16-8. PubMed ID: 18793601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
    Adam D; Fehnle K
    Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic protein contaminants in pneumococcal vaccines.
    Yu J; Briles DE; Englund JA; Hollingshead SK; Glezen WP; Nahm MH
    J Infect Dis; 2003 Mar; 187(6):1019-23. PubMed ID: 12660950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the clinical application of pneumococcal vaccine. Distribution of Streptococcus pneumoniae in Japan].
    Fukumi H; Kaneko Y; Agata T; Takayanagi M; Yoshioka H; Fujita K; Kawana R; Shimada K; Inamatsu T; Urayama K
    Kansenshogaku Zasshi; 1984 Jan; 58(1):39-53. PubMed ID: 6434647
    [No Abstract]   [Full Text] [Related]  

  • 14. Phosphorylcholine-carbohydrate-protein conjugates efficiently induce hapten-specific antibodies which recognize both Streptococcus pneumoniae and Neisseria meningitidis: a potential multitarget vaccine against respiratory infections.
    Bay S; Huteau V; Zarantonelli ML; Pires R; Ughetto-Monfrin J; Taha MK; England P; Lafaye P
    J Med Chem; 2004 Jul; 47(16):3916-9. PubMed ID: 15267227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
    Villena J; Medina M; Raya R; Alvarez S
    Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pneumococcal vaccine. Its efficacy in patients 55 and over].
    Marchand R
    Can Fam Physician; 1993 May; 39():1144-9. PubMed ID: 8499794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplies of pneumococcal vaccine.
    Commun Dis Rep CDR Wkly; 1992 Nov; 2(45):205. PubMed ID: 1285118
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of new pediatric vaccines: progress and challenges].
    Siegrist CA
    Rev Med Suisse Romande; 1998 Apr; 118(4):395-401. PubMed ID: 9623292
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma.
    Lahood N; Emerson SS; Kumar P; Sorensen RU
    Ann Allergy; 1993 Apr; 70(4):289-94. PubMed ID: 8466093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial response: Predicting protection against encapsulated pathogens.
    Janoff EN; Rubins JB
    Clin Infect Dis; 1999 Aug; 29(2):289-91. PubMed ID: 10476728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.